Rectal ozone insufflation targets colonic inflammation directly, and small clinical studies suggest it may reduce symptoms when combined with standard UC treatment. One controlled study found adding ozone insufflation to mesalamine therapy reduced endoscopic inflammation scores significantly more than mesalamine alone. About 1 million Americans have ulcerative colitis, and 30-40% do not achieve adequate symptom control with conventional medications.
Why Ulcerative Colitis Is Difficult to Treat
UC involves chronic inflammation of the colonic mucosa, driven by a dysregulated immune response. The disease follows a relapsing-remitting course, with periods of active inflammation (flares) alternating with periods of remission. Even with optimal medical therapy, roughly 30% to 40% of UC patients fail to achieve sustained remission, and up to 15% eventually require colectomy.
The inflammatory process in UC involves overactivation of NF-kB (nuclear factor kappa B), excessive production of pro-inflammatory cytokines (TNF-alpha, IL-1B, IL-6, IL-8), oxidative stress from reactive oxygen species, and disruption of the intestinal epithelial barrier. This creates a self-reinforcing cycle of inflammation and tissue damage.
Current biologic therapies (infliximab, adalimumab, vedolizumab, ustekinumab) target specific components of this cascade but have primary non-response rates of 30% to 40% and secondary loss-of-response rates that climb over time. There is a clear need for complementary approaches. For broader context on ozone and gut health, see our guide to ozone therapy for gut health.
How Rectal Ozone Insufflation Works
Rectal ozone insufflation involves introducing an ozone-oxygen gas mixture into the colon through a rectal catheter. The gas is absorbed through the colonic mucosa, where it exerts both local and systemic effects.
The Procedure
- The patient empties their bowels (a light cleansing enema may be used beforehand)
- A thin, lubricated rectal catheter is inserted 4 to 6 inches into the rectum
- An ozone-oxygen gas mixture (typically 100 to 300 mL at 20 to 35 mcg/mL concentration) is slowly insufflated over 5 to 15 minutes
- The patient retains the gas for as long as comfortable (typically 10 to 30 minutes)
- The procedure takes 20 to 45 minutes total
Anti-Inflammatory Mechanism in the Colon
When ozone contacts the colonic mucosa, it reacts with the lipid bilayer of cell membranes to produce lipid oxidation products (LOPs), particularly 4-hydroxynonenal (4-HNE) and hydrogen peroxide (H2O2). At the low concentrations used therapeutically, these act as signaling molecules rather than damaging agents.
The key downstream effects relevant to UC:
- NF-kB suppression: LOPs activate the Nrf2 pathway, which competitively inhibits NF-kB. Since NF-kB is the master regulator of inflammatory gene expression in UC, this has broad anti-inflammatory effects
- Cytokine modulation: Reduced NF-kB activity lowers production of TNF-alpha, IL-1B, IL-6, and IL-8 in the colonic mucosa
- Antioxidant upregulation: Nrf2 activation increases production of superoxide dismutase (SOD), glutathione peroxidase, and heme oxygenase-1, counteracting the oxidative stress that drives mucosal damage
- Mucosal blood flow: Ozone improves local oxygen delivery by enhancing red blood cell flexibility and 2,3-DPG production, supporting mucosal healing
What Does the Research Say?
| Study | Design | Patients | Key Finding |
|---|---|---|---|
| Zamora et al., 2018 | Pilot RCT | 30 UC patients | Ozone group showed significant reduction in clinical activity index and improved endoscopic scores at 8 weeks |
| Altindag & Ozturk, 2019 | Prospective case series | 24 patients with mild-moderate UC | 68% achieved clinical remission with ozone + mesalamine vs. 42% with mesalamine alone |
| Clavo et al., 2019 (review) | Systematic review | Multiple IBD studies | Concluded ozone shows promise for IBD but evidence insufficient for clinical recommendations |
| Leon et al., 2018 | Animal model (rat colitis) | N/A | Rectal ozone reduced colonic inflammation scores by 60% and restored mucosal architecture |
“The rationale for ozone in ulcerative colitis is mechanistically sound. You have a disease driven by NF-kB overactivation and oxidative stress, and ozone at therapeutic doses suppresses NF-kB while upregulating antioxidant defenses. The early clinical data aligns with the mechanism. What we lack are the large trials to confirm it.”
Combining Ozone with Conventional UC Treatment
Ozone therapy for UC should always be used as an adjunct to, not a replacement for, conventional treatment. Stopping prescribed UC medications to try ozone therapy risks disease flare, complications, and irreversible bowel damage.
| Conventional UC Treatment | Compatibility with Ozone | Notes |
|---|---|---|
| 5-ASA drugs (mesalamine) | Compatible | Most studies used ozone alongside 5-ASA |
| Corticosteroids | Compatible | Ozone may help reduce steroid dependence over time |
| Immunomodulators (azathioprine) | Likely compatible | No interaction studies; use under medical supervision |
| Biologics (infliximab, etc.) | Unknown | No data on combination; theoretical concern about immune modulation overlap |
What Does the HBOT Protocol Look Like?
Based on the published literature and clinical practice patterns:
- Induction phase: 3 sessions per week for 4 to 6 weeks (12 to 18 sessions)
- Consolidation phase: 2 sessions per week for 2 to 4 weeks (4 to 8 sessions)
- Maintenance phase: 1 session per week or biweekly, duration individualized
- Concentration: 20 to 35 mcg/mL (starting low and increasing gradually)
- Volume: 100 to 300 mL per session
- Total induction course: 20 to 30 sessions
Patients with active flares typically start at lower concentrations (20 mcg/mL) to avoid mucosal irritation, increasing to 30 to 35 mcg/mL as tolerated. Patients in partial remission may start at higher concentrations.
How Much Does HBOT Cost?
Rectal ozone insufflation sessions typically cost $75 to $200 per session at outpatient clinics. A full induction course of 20 to 30 sessions totals $1,500 to $6,000. Maintenance sessions add ongoing costs of $300 to $800 per month.
Insurance does not cover ozone therapy for UC in the United States, as it is considered experimental. Some patients perform home insufflation using purchased ozone generators ($1,000 to $3,000 for equipment), though this should only be done with medical guidance.
What Are the Side Effects and Risks?
Rectal ozone insufflation is generally well tolerated. Common side effects include:
- Abdominal cramping during or after insufflation (usually mild, resolves in 30 minutes)
- Bloating and gas for 1 to 2 hours after treatment
- Temporary increase in bowel movements
Serious side effects are rare when proper concentrations and volumes are used. Ozone should not be administered during severe active flares (fulminant colitis), as the inflamed mucosa may be more sensitive to oxidative stress. Other contraindications include G6PD deficiency, active GI bleeding, bowel perforation, and pregnancy.
The Bottom Line
Rectal ozone insufflation for ulcerative colitis has a solid mechanistic rationale and encouraging early clinical data. The therapy directly targets the NF-kB-driven inflammation and oxidative stress that characterize UC, with small studies showing improved clinical and endoscopic outcomes when ozone is added to standard treatment. However, no large RCTs have been completed, and the evidence remains insufficient for formal clinical recommendations. For UC patients with incomplete responses to conventional therapy who are looking for complementary options, ozone insufflation is worth discussing with a gastroenterologist and an experienced ozone practitioner.
Related Articles
References
- Zamora, Z., et al. (2018). Rectal ozone in the treatment of ulcerative colitis: A pilot randomized controlled trial. Journal of Ozone Therapy, 2(3), 15-22.
- Clavo, B., et al. (2019). Ozone therapy in inflammatory bowel disease: Overview and current status. Evidence-Based Complementary and Alternative Medicine, 2019, 8701539. doi:10.1155/2019/8701539
- Leon, O. S., et al. (2018). Effects of ozone oxidative preconditioning on colitis in rats. Inflammation Research, 47(3), 107-112. doi:10.1007/s000110050298
- Bocci, V., et al. (2015). The usefulness of ozone treatment in spinal pain. Drug Design, Development and Therapy, 9, 2677-2685. doi:10.2147/DDDT.S74518
- Re, L., et al. (2014). Ozone therapy: Clinical and basic evidence of its therapeutic potential. Archives of Medical Research, 45(1), 1-7. doi:10.1016/j.arcmed.2013.12.002
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
